Abstract:BACKGROUND: Benign prostatic hyperplasia (BPH) is the most common urologic disease affecting aging men. The pathogenesis of BPH is multi-factorial, and chronic inflammation (CI) might be the central mechanism. Interleukin (IL)-27 signaling has been suggested as a modulator in autoimmune and inflammatory conditions. In this study, we used microarray experiments to analyze gene expression and molecular phenotypic associated with BPH progression, with a particular focus on CI and IL-27/IL-27RA signaling, and verified the microarray data in cell biology experiments.METHODS: Thirty BPH patients' specimens and clinical parameters were analyzed. BPH patients were divided into two groups based on the average prostate volume (41.5 mL): group 1, ≤40 mL; and group 2, >40 mL. Microarray experiments were conducted to identify differentially expressed genes (DEGs) by applying appropriate biostatistics to normalize and analyze the dataset. The candidate gene (IL27RA) was validated by quantitative reverse transcriptase-PCR (qRT-PCR) and immunohistochemistry (IHC). The interaction of IL27RA with genes involved in canonical inflammation-associated pathways was investigated by cell biology experiments.RESULTS: Eighty-three percent of BPH specimens contained inflammatory infiltrates, and the predominant type was CI. The serum PSA levels and prevalence of CI were higher in group 2. Microarray experiments identified 361 DEGs between these 2 groups. IL27RA was down-regulated and associated with prominent CI in BPH tissues of group 2. Validated by qRT-PCR and IHC, the results showed IL-27RA might modulate CI and progression of BPH. Thus, we investigated the interaction of IL27RA with TLR4, IL6, and IL8, which were involved in inflammation-associated pathways. We found the activation of IL-27RA after IL-27 treatment led to phosphorylation of STAT1 and STAT3 in prostate epithelial cells. By comparative treatments with lipopolysaccharide (LPS), IL-27, or combination, we found that IL-27/IL-27RA signaling suppressed the production of inflammatory cytokines, IL-6 and IL-8, induced by LPS/TLR4 pathway.CONCLUSIONS: Our study revealed that down-regulation of IL27RA in prostate tissue was associated with higher prevalence of CI and BPH progression. IL-27/IL-27RA signaling suppressed the LPS/TLR4 pathway. We conclude the IL-27/IL-27RA signaling might modulate CI and provide potential therapeutic strategies to prevent BPH progression.

MP06-05 UPREGULATED INTERLEUKIN 21 RECEPTOR ENHANCES PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION PROCESS IN BENIGN PROSTATIC HYPERPLASIA

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia

IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model

Proliferative mechanism of benign prostatic hyperplasia by NLRP3 inflammasome through the complement pathway

Inflammation Induced by Lipopolysaccharide Advanced Androgen Receptor Expression and Epithelial-Mesenchymal Transition Progress in Prostatitis and Prostate Cancer.

NELL2 Modulates Cell Proliferation and Apoptosis via ERK Pathway in the Development of Benign Prostatic Hyperplasia.

Relationship Between Interleukin-8 Levels in Expressed Prostatic Secretion and Expressions of Bfgf and Bcl-2 in Benign Prostatic Hyperplasia

Interleukin 21 and Its Receptor Play A Role in Proliferation, Migration and Invasion of Breast Cancer Cells

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia

Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway

The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer

The expressions of IL-1β, IL-6, IL-8, and ISG54 in benign prostatic hyperplasia combined with histological prostatitis

THE ANDROGEN RECEPTOR PLAYS DIFFERENT ROLES IN MACROPHAGE-INDUCED PROLIFERATION IN PROSTATE STROMAL CELLS BETWEEN TRANSITIONAL AND PERIPHERAL ZONES OF BENIGN PROSTATIC HYPERTROPHY

DNMT1 Regulates IL-6- and TGF-β1-Induced Epithelial Mesenchymal Transition in Prostate Epithelial Cells

Differential Research of Inflammatory and Related Mediators in BPH, Histological Prostatitis and PCa.